
    
      This is a randomized, double-blind, placebo-controlled study in healthy volunteers designed
      to assess the safety, tolerability and PK of FM101. This study will consist of 3 parts: a SAD
      part, a single dose FE part and a MAD part. Each subject is to participate in only 1 part of
      the study.
    
  